Mega Lifesciences PCL
SET:MEGA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
33.5
44
|
| Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Mega Lifesciences PCL
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | TH |
| Market Cap | 29.6B THB |
| Gross Margin |
49%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 749.7B USD |
| Gross Margin |
81%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | DK |
| Market Cap | 3.3T DKK |
| Gross Margin |
85%
|
| Country | US |
| Market Cap | 372B USD |
| Gross Margin |
69%
|
| Country | US |
| Market Cap | 257.3B USD |
| Gross Margin |
77%
|
| Country | CH |
| Market Cap | 201.7B CHF |
| Gross Margin |
73%
|
| Country | UK |
| Market Cap | 163B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 179.6B CHF |
| Gross Margin |
75%
|
| Country | US |
| Market Cap | 146B USD |
| Gross Margin |
71%
|
Mega Lifesciences PCL
Glance View
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Mega Lifesciences PCL's most recent financial statements, the company has Gross Margin of 48.6%.
You don't have any saved screeners yet
